The Revenue Hiding in Your Existing Patient Base

The average hearing practice has 400–900 patients who purchased hearing aids 3+ years ago and haven't been seen since. At a $3,500 average upgrade value, that's $1.4M–$3.15M in potential recall revenue sitting dormant in your database. Practices that run consistent, multi-touch recall programs re-activate 25–40% of these patients within 90 days. Practices that send a single annual letter re-activate 3–8%. The difference is the system.

Why Single-Touch Recall Fails

A single recall letter or phone call fails for a predictable reason: life is busy, and patients procrastinate. Someone who receives a recall letter on a Monday with good intentions will put it on the counter, forget it by Wednesday, and never call. The same patient, if they receive a letter on Monday, a text message Thursday, and a personal phone call the following week, is dramatically more likely to book — because the repeated touchpoints break through the inertia.

The 6-Week Multi-Touch Recall Sequence

An effective recall sequence works in three phases over six weeks. Week one: a personal letter from the audiologist with a specific reason to come in (technology has advanced, their aids are due for service, insurance benefits may be expiring). Week two: an SMS reminder with a direct booking link. Week three: a phone call from the front desk. Week four: if no response, a brief "final notice" email. Week six: one final SMS before marking the patient as a non-responder and scheduling them again in 6 months. Documented multi-touch recall programs like this consistently generate 30–40% reactivation.

Segmenting Your Recall List

Not all recall patients are equal. Prioritize by: hearing aid age (3–4 year olds are the hottest segment — ready for an upgrade); insurance reset (patients whose insurance benefits have renewed); and historical spend (patients who previously purchased premium devices are most likely to upgrade to premium again). Contact these segments first, with messaging tailored to their specific situation rather than generic recall copy.

Measuring What Works

Every recall sequence should be tracked at the individual level: who was contacted, which touchpoint generated the response, what they were offered, and whether they purchased. This data, accumulated over 6–12 months, tells you which sequence length, which channel, and which message generates the highest re-activation rate for your specific patient population. Without tracking, every recall campaign is essentially starting from scratch.